IL17A and hepatocellular carcinoma: Hu et al. demonstrated that acetate inhibits histone deacetylase activity and increases acetylation of SRY-box transcription factor 13 (Sox13) at the Lys30, thereby reducing IL-17A production in tumor-derived ILC3s and suppressing HCC progression 62.